CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization. (Q51449118)

5 April 2018

title

CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization. (English)

1 reference

5 April 2018

0 references

5

Nils Y Lycke

1 reference

5 April 2018

author name string

Ellen Marks

1

1 reference

5 April 2018

Anja Helgeby

2

1 reference

5 April 2018

Jan O Andersson

3

1 reference

5 April 2018

Karin Schön

4

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 September 2011

1 reference

5 April 2018

European Journal of Immunology

published in

1 reference

5 April 2018

volume

41

1 reference

5 April 2018

issue

9

1 reference

5 April 2018

page(s)

2642-2653

1 reference

5 April 2018

Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Differential roles of B cells and IFN-gamma-secreting CD4(+) T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Immunization for protection of the reproductive tract: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Immunologic uniqueness of the genital tract: challenge for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Estradiol-induced vaginal mucus inhibits antigen penetration and CD8(+) T cell priming in response to intravaginal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Neutralizing antibodies in mucosal secretions: IgG or IgA?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

A predominant role for antibody in acquired immunity to chlamydial genital tract reinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Role for dendritic cells in immunoregulation during experimental vaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Differential regulation of CD4 lymphocyte recruitment between the upper and lower regions of the genital tract during Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

The female lower genital tract is a privileged compartment with IL-10 producing dendritic cells and poor Th1 immunity following Chlamydia trachomatis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

Immune protection against HSV-2 in B-cell-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

7 January 2021

Adoptive transfer of transgenic T cells to study mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

7 January 2021

Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

7 January 2021

The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

7 January 2021

Langerhans cells prime IL-17-producing T cells and dampen genital cytotoxic responses following mucosal immunization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

7 January 2021

Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041297

7 January 2021

Identifiers

DOI

10.1002/EJI.201041297

1 reference

5 April 2018

1 reference

5 April 2018